National Comprehensive Cancer Network investigational drug service consensus recommendations.

Authors :: Amin, Sapna
Polley, Stephen
DeFrates, Sean
Finnes, Heidi D
Kinsman, Katharine
MacDonald, Elyse
Dean, Latanya
DeWitt, Lorri
Harvey, Caroline
Johnston, Susan
Leung, Tzewah Vivian
Moll, Emily A
O'Neill, Gerald P
Redic, Kimberly A
Park, Sharon F
Source :: American Journal of Health-System Pharmacy. March 15 2022, Vol. 79 Issue 6, p486-491. 6p. 2 Charts.
Publication Year :: 2022
Abstract: The article highlights the critical role that the investigational drug services (IDS) pharmacist plays in ensuring safe medical practices for patients receiving investigational medications. Topics include current gaps in investigational drug practices, IDS work group recommendations, and IDS participation in use of interactive response technology (IRT).

Subjects :: *THERAPEUTIC use of antineoplastic agents
*CONSENSUS (Social sciences)
*PROFESSIONAL practice
*OCCUPATIONAL roles
*TEMPERATURE
*HAZARDOUS substances
*INVESTIGATIONAL drugs
*MEDICAL technology
*DRUG packaging
*EVIDENCE-based medicine
*HOSPITAL pharmacies
*QUALITY assurance
*DRUG labeling
*MEDICAL records
*TUMORS
*PHARMACEUTICAL industry
*DRUG storage
*ONCOLOGY

Full Text Access

Tools